These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38093705)

  • 1. The dual role of regulatory T cells in hepatitis B virus infection and related hepatocellular carcinoma.
    He J; Miao R; Chen Y; Wang H; Liu M
    Immunology; 2024 Apr; 171(4):445-463. PubMed ID: 38093705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses.
    Zhang HH; Mei MH; Fei R; Liu F; Wang JH; Liao WJ; Qin LL; Wei L; Chen HS
    J Viral Hepat; 2010 Mar; 17 Suppl 1():34-43. PubMed ID: 20586932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Immune Cells in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma.
    Cho HJ; Cheong JY
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral immune characteristics of hepatitis B virus-related hepatocellular carcinoma.
    Sun R; Li J; Lin X; Yang Y; Liu B; Lan T; Xiao S; Deng A; Yin Z; Xu Y; Xiang Z; Wu B
    Front Immunol; 2023; 14():1079495. PubMed ID: 37077908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune Regulation by T Regulatory Cells in Hepatitis B Virus-Related Inflammation and Cancer.
    Trehanpati N; Vyas AK
    Scand J Immunol; 2017 Mar; 85(3):175-181. PubMed ID: 28109025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significant roles of regulatory T cells and myeloid derived suppressor cells in hepatitis B virus persistent infection and hepatitis B virus-related HCCs.
    Kondo Y; Shimosegawa T
    Int J Mol Sci; 2015 Feb; 16(2):3307-22. PubMed ID: 25654227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidimensional analyses reveal distinct immune microenvironment in hepatitis B virus-related hepatocellular carcinoma.
    Lim CJ; Lee YH; Pan L; Lai L; Chua C; Wasser M; Lim TKH; Yeong J; Toh HC; Lee SY; Chan CY; Goh BK; Chung A; Heikenwälder M; Ng IO; Chow P; Albani S; Chew V
    Gut; 2019 May; 68(5):916-927. PubMed ID: 29970455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The positive feedback loop of furin and TGFβ1 enhances the immune responses of Tregs to hepatocellular carcinoma cells and hepatitis B virus in vitro.
    Qiu H; Wang N; Lin D; Yuan Y; Li J; Mao D; Meng Y
    Cell Biol Int; 2022 Aug; 46(8):1215-1226. PubMed ID: 35349767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-cell landscape of immune cells during the progression from HBV infection to HBV cirrhosis and HBV-associated hepatocellular carcinoma.
    Bai Q; Li R; He X; Hong X; Yan Y; Zhao Z; Lin H; Tacke F; Engelmann C; Hu T
    Front Immunol; 2023; 14():1320414. PubMed ID: 38116005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratumoral stem-like CCR4+ regulatory T cells orchestrate the immunosuppressive microenvironment in HCC associated with hepatitis B.
    Gao Y; You M; Fu J; Tian M; Zhong X; Du C; Hong Z; Zhu Z; Liu J; Markowitz GJ; Wang FS; Yang P
    J Hepatol; 2022 Jan; 76(1):148-159. PubMed ID: 34689996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low hepatitis B virus-specific T-cell response in males correlates with high regulatory T-cell numbers in murine models.
    Kosinska AD; Pishraft-Sabet L; Wu W; Fang Z; Lenart M; Chen J; Dietze KK; Wang C; Kemper T; Lin Y; Yeh SH; Liu J; Dittmer U; Yuan Z; Roggendorf M; Lu M
    Hepatology; 2017 Jul; 66(1):69-83. PubMed ID: 28295453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Investigation of Regulatory T Cells and Secreted Immunomodulatory Cytokine IL-10 Levels in Patients with Hepatitis B].
    Tuyji Tok Y; Şener AG; Aksoy Gökmen A; Demirdal T; Kaya S
    Mikrobiyol Bul; 2020 Apr; 54(2):266-278. PubMed ID: 32723282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Significance of B7-H3 Expression During the Progression of Hepatitis B Virus Infection.
    Gao F; Xu JC; Zhu L; Chen H; Zhu XY; You XR; Li SX; Zhu CL; Yang C; Zhu CW; Xu P
    Viral Immunol; 2018 Dec; 31(10):668-675. PubMed ID: 30481143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p65/miR-23a/CCL22 axis regulated regulatory T cells recruitment in hepatitis B virus positive hepatocellular carcinoma.
    Li ZQ; Wang HY; Zeng QL; Yan JY; Hu YS; Li H; Yu ZJ
    Cancer Med; 2020 Jan; 9(2):711-723. PubMed ID: 31769216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinoma.
    Kubo S; Takemura S; Tanaka S; Shinkawa H; Nishioka T; Nozawa A; Kinoshita M; Hamano G; Ito T; Urata Y
    World J Gastroenterol; 2015 Jul; 21(27):8249-55. PubMed ID: 26217076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune suppression in chronic hepatitis B infection associated liver disease: A review.
    Li TY; Yang Y; Zhou G; Tu ZK
    World J Gastroenterol; 2019 Jul; 25(27):3527-3537. PubMed ID: 31367154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrahepatic T helper 17 cells recruited by hepatitis B virus X antigen-activated hepatic stellate cells exacerbate the progression of chronic hepatitis B virus infection.
    Zhang H; Yan X; Yang C; Zhan Q; Fu Y; Luo H; Luo H
    J Viral Hepat; 2020 Nov; 27(11):1138-1149. PubMed ID: 32559002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs as therapeutic strategy for hepatitis B virus-associated hepatocellular carcinoma: current status and future prospects.
    Tan YL; Chen WN
    World J Gastroenterol; 2014 May; 20(20):5973-86. PubMed ID: 24876720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-35 Suppresses Interleukin-9-Secreting CD4
    Zhang Q; Yang L; Liu S; Zhang M; Jin Z
    Front Immunol; 2021; 12():645835. PubMed ID: 34177894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ARID1A deficiency promotes progression and potentiates therapeutic antitumour immunity in hepatitis B virus-related hepatocellular carcinoma.
    Xing T; Li L; Rao X; Zhao J; Chen Y; Ju G; Xu Y; Gao X; Dong G; Xia X; Guan Y; Zhang L; Wen Z; Liang J
    BMC Gastroenterol; 2024 Jan; 24(1):11. PubMed ID: 38166741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.